trending Market Intelligence /marketintelligence/en/news-insights/trending/rmuyyq3hxcfvgxf2cchdsw2 content esgSubNav
In This List

Processa Pharmaceuticals appoints CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Processa Pharmaceuticals appoints CFO

Processa Pharmaceuticals Inc. appointed James Stanker as its CFO.

The Hanover, Md.-based company said Stanker brings more than 25 years of financial and executive leadership experience to Processa in the areas of accounting principles and audit standards, regulatory reporting and fiscal management and strategy.

Processa Pharmaceuticals is developing a medicine for a skin condition known as necrobiosis lipoidica.